JPRN-UMIN000003642Recruiting未知
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001) - A phase II trial of neoadjuvant chemotherapy with DCS for radically resectable advanced gastric carcinoma (KDOG 1001)
Kitasato University School of Medicine0 sites40 target enrollmentStarted: May 19, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Active synchronous malignancy 2. History of serious drug hypersensitivity 3. Severe pulmonary disease (interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema or etc) 4. Severe heart disease (congestive heart failure, symptomatic ischemic heart disease, uncontrolled arrhythmia, or etc) 5. Severe mental disorders, neurological disease 6. Pregnant or lactation women, or women with the possibility of the pregnancy and men who want let to pregnancy 7. Patients who are judged inappropriate for the entry into this study by the investigator
Investigators
Similar Trials
Unknown
Phase 2
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25
Recruiting
Phase 2
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Recruiting
Phase 2
A phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin followed by surgery in cStageIII advanced gastric cancer patientsGastric cancerJPRN-UMIN000023405Wakayama Medical University, Second Department of Surgery48
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40